Prospective, monocentric, observational study of the long-term effectiveness of omalizumab in chronic urticaria.
chronic urticaria
effectiveness
omalizumab
real-word data
Journal
Allergologie select
ISSN: 2512-8957
Titre abrégé: Allergol Select
Pays: Germany
ID NLM: 101722686
Informations de publication
Date de publication:
2023
2023
Historique:
received:
21
09
2022
accepted:
07
12
2022
entrez:
16
1
2023
pubmed:
17
1
2023
medline:
17
1
2023
Statut:
epublish
Résumé
Omalizumab, a monoclonal antibody targeting IgE, has been approved in 2014 for the treatment of H1 antihistamine-refractory chronic urticaria. Data on long-term effectiveness and predictive factors for treatment response are currently limited. In this monocentric, prospective, observational study, 112 patients with chronic spontaneous urticaria (CSU) and 32 patients with chronic inducible urticaria (CIndU) were included. In addition to a rapid response, omalizumab also showed good effectiveness on both forms of chronic urticaria over 2 years. Low total IgE and elevated
Identifiants
pubmed: 36644013
doi: 10.5414/ALX02376E
pmc: PMC9835204
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1-7Informations de copyright
© Dustri-Verlag Dr. K. Feistle.
Références
J Eur Acad Dermatol Venereol. 2019 May;33(5):918-924
pubmed: 30451325
Allergy. 2018 Mar;73(3):705-712
pubmed: 29083482
J Allergy Clin Immunol. 2017 Mar;139(3):1059-1061.e1
pubmed: 27838346
Allergy. 2022 Mar;77(3):734-766
pubmed: 34536239
Allergy Asthma Proc. 2019 Jul 1;40(4):273-278
pubmed: 31262381
Front Immunol. 2021 May 03;12:657211
pubmed: 34012441
JAMA Dermatol. 2019 Jan 1;155(1):29-38
pubmed: 30427977
Ann Allergy Asthma Immunol. 2018 Oct;121(4):474-478
pubmed: 29949781
J Allergy Clin Immunol. 2017 Dec;140(6):1710-1713.e11
pubmed: 28625805
N Engl J Med. 2013 Mar 7;368(10):924-35
pubmed: 23432142
Br J Dermatol. 2018 Sep;179(3):776-777
pubmed: 29582427
Br J Dermatol. 2016 Aug;175(2):404-6
pubmed: 26972689
Allergy. 2021 Oct;76(10):2965-2981
pubmed: 33539587
Immunotargets Ther. 2021 Feb 17;10:27-45
pubmed: 33628747
J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1386-1388.e1
pubmed: 29175369
Acta Derm Venereol. 2017 Jun 9;97(6):698-704
pubmed: 28303277
Arch Dermatol. 2008 Jan;144(1):35-9
pubmed: 18209166
J Allergy Clin Immunol. 2018 Feb;141(2):638-649
pubmed: 28751232
Allergy. 2013 Jan;68(1):27-36
pubmed: 23157716